HEADER PROTEIN BINDING 06-SEP-11 3ZZZ TITLE CRYSTAL STRUCTURE OF A RAVER1 PRI4 PEPTIDE IN COMPLEX WITH TITLE 2 POLYPYRIMIDINE TRACT BINDING PROTEIN RRM2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYPYRIMIDINE TRACT-BINDING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RNA RECOGNITION MOTIF 2, RESIDUES 156-285; COMPND 5 SYNONYM: PTB, 57 KDA RNA-BINDING PROTEIN PPTB-1, HETEROGENEOUS COMPND 6 NUCLEAR RIBONUCLEOPROTEIN I, HNRNP I; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: RIBONUCLEOPROTEIN PTB-BINDING 1; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: MOTIF PRI4, RESIDUES 680-692; COMPND 12 SYNONYM: RAVER1, PROTEIN RAVER-1; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: THIS FRAGMENT IS ACTUALLY FUSED TO THE N-TERMINUS OF COMPND 15 MOLECULE 1, SEE REMARK 999 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS PROTEIN BINDING, PEPTIDE BINDING, RNA RECOGNITION MOTIF EXPDTA X-RAY DIFFRACTION AUTHOR A.JOSHI,O.KOTIK-KOGAN,S.CURRY REVDAT 2 20-DEC-23 3ZZZ 1 REMARK REVDAT 1 28-DEC-11 3ZZZ 0 JRNL AUTH A.JOSHI,M.B.COELHO,O.KOTIK-KOGAN,P.J.SIMPSON,S.J.MATTHEWS, JRNL AUTH 2 C.W.SMITH,S.CURRY JRNL TITL CRYSTALLOGRAPHIC ANALYSIS OF POLYPYRIMIDINE TRACT-BINDING JRNL TITL 2 PROTEIN-RAVER1 INTERACTIONS INVOLVED IN REGULATION OF JRNL TITL 3 ALTERNATIVE SPLICING. JRNL REF STRUCTURE V. 19 1816 2011 JRNL REFN ISSN 0969-2126 JRNL PMID 22153504 JRNL DOI 10.1016/J.STR.2011.09.020 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1123728.720 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 36156 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1789 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5685 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 293 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1723 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 132 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.30000 REMARK 3 B22 (A**2) : -4.84000 REMARK 3 B33 (A**2) : 3.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.80000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.50 REMARK 3 BSOL : 67.88 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED. THE REMARK 3 CRYSTALLISED PROTEIN HAS A RAVER1 PEPTIDE GENETICALLY FUSED AS REMARK 3 AN N-TERMINAL EXTENSION OF PTB RRM3. OWING TO LINKER DISORDER WE REMARK 3 CANNOT DETERMINE WHICH RRM DOMAIN (CHAINS A, B) IS COVALENTLY REMARK 3 LINKED TO WHICH RAVER1 PEPTIDE (CHAINS C,D). REMARK 4 REMARK 4 3ZZZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290049531. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97960 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36184 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 35.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.3.1 REMARK 200 STARTING MODEL: PDB ENTRY 3ZZY REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SEE PAPER., PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 37.24000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.19000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 37.24000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.19000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 156 REMARK 465 VAL A 157 REMARK 465 GLN A 158 REMARK 465 SER A 159 REMARK 465 GLY A 160 REMARK 465 ASN A 161 REMARK 465 LEU A 162 REMARK 465 ALA A 163 REMARK 465 LEU A 164 REMARK 465 ALA A 165 REMARK 465 ALA A 166 REMARK 465 SER A 167 REMARK 465 ALA A 168 REMARK 465 ALA A 169 REMARK 465 ALA A 170 REMARK 465 VAL A 171 REMARK 465 ASP A 172 REMARK 465 ALA A 173 REMARK 465 GLY A 174 REMARK 465 MET A 175 REMARK 465 ALA A 176 REMARK 465 MET A 177 REMARK 465 ALA A 178 REMARK 465 GLY A 179 REMARK 465 SER A 285 REMARK 465 SER B 156 REMARK 465 VAL B 157 REMARK 465 GLN B 158 REMARK 465 SER B 159 REMARK 465 GLY B 160 REMARK 465 ASN B 161 REMARK 465 LEU B 162 REMARK 465 ALA B 163 REMARK 465 LEU B 164 REMARK 465 ALA B 165 REMARK 465 ALA B 166 REMARK 465 SER B 167 REMARK 465 ALA B 168 REMARK 465 ALA B 169 REMARK 465 ALA B 170 REMARK 465 VAL B 171 REMARK 465 ASP B 172 REMARK 465 ALA B 173 REMARK 465 GLY B 174 REMARK 465 MET B 175 REMARK 465 ALA B 176 REMARK 465 MET B 177 REMARK 465 ALA B 178 REMARK 465 GLY B 179 REMARK 465 SER B 285 REMARK 465 GLY C 677 REMARK 465 ALA C 678 REMARK 465 MET C 679 REMARK 465 GLY C 680 REMARK 465 SER C 681 REMARK 465 GLY C 689 REMARK 465 PRO C 690 REMARK 465 GLY C 691 REMARK 465 PRO C 692 REMARK 465 GLY D 677 REMARK 465 ALA D 678 REMARK 465 MET D 679 REMARK 465 GLY D 680 REMARK 465 SER D 681 REMARK 465 GLY D 689 REMARK 465 PRO D 690 REMARK 465 GLY D 691 REMARK 465 PRO D 692 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 180 CG CD OE1 NE2 REMARK 470 ARG A 185 CD NE CZ NH1 NH2 REMARK 470 LYS A 218 CG CD CE NZ REMARK 470 ASP A 256 CG OD1 OD2 REMARK 470 LYS A 266 CE NZ REMARK 470 LYS A 271 CE NZ REMARK 470 GLN B 180 CG CD OE1 NE2 REMARK 470 ARG B 185 CD NE CZ NH1 NH2 REMARK 470 LYS B 218 CG CD CE NZ REMARK 470 GLN B 244 CD OE1 NE2 REMARK 470 LYS B 259 CG CD CE NZ REMARK 470 LYS B 266 CE NZ REMARK 470 ASP B 270 CG OD1 OD2 REMARK 470 LYS B 271 CG CD CE NZ REMARK 470 GLU C 683 CG CD OE1 OE2 REMARK 470 GLU D 683 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 269 -153.00 -157.04 REMARK 500 LYS B 218 -98.73 -113.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 1285 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 1286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 1287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 1288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD D 1689 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QM9 RELATED DB: PDB REMARK 900 NMR, REPRESENTATIVE STRUCTURE REMARK 900 RELATED ID: 1SJR RELATED DB: PDB REMARK 900 NMR STRUCTURE OF RRM2 FROM HUMAN POLYPYRIMIDINE TRACTBINDING REMARK 900 PROTEIN ISOFORM 1 (PTB1) REMARK 900 RELATED ID: 2ADB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEINRBD2 REMARK 900 COMPLEXED WITH CUCUCU RNA REMARK 900 RELATED ID: 2AD9 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEINRBD1 REMARK 900 COMPLEXED WITH CUCUCU RNA REMARK 900 RELATED ID: 2ADC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF POLYPYRIMIDINE TRACT BINDING PROTEINRBD34 REMARK 900 COMPLEXED WITH CUCUCU RNA REMARK 900 RELATED ID: 2EVZ RELATED DB: PDB REMARK 900 STRUCTURE OF RNA BINDING DOMAINS 3 AND 4 OF POLYPYRIMIDINETRACT REMARK 900 BINDING PROTEIN REMARK 900 RELATED ID: 1SJQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF RRM1 FROM HUMAN POLYPYRIMIDINE TRACTBINDING REMARK 900 PROTEIN ISOFORM 1 (PTB1) REMARK 900 RELATED ID: 1WI6 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE RNA BINDING DOMAIN FROM MOUSEHYPOTHETICAL REMARK 900 PROTEIN BAB23670 REMARK 900 RELATED ID: 3ZZY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A RAVER1 PRI3 PEPTIDE IN COMPLEX WITH REMARK 900 POLYPYRIMIDINE TRACT BINDING PROTEIN RRM2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 FIRST 3 RESIDUES (GAM) ARE VECTOR DERIVED. RESIDUES 4 - 16 REMARK 999 CORRESPOND TO RESIDUES 680-692 OF RAVER1 (PRI4 MOTIF). REMARK 999 THESE 16 RESIDUES ARE FUSED GENETICALLY TO PTB RRM2 ( REMARK 999 RECORDED AS CHAINS A AND B). BECAUSE OF LINKER DISORDER WE REMARK 999 CANNOT DETERMINE WHICH RRM DOMAIN (CHAINS A, B) IS COVALENTLY REMARK 999 LINKED TO WHICH RAVER1 PEPTIDE (CHAINS C,D). REMARK 999 METHIONINE 1 IN RAVER1 IS AN INITIATOR MET AND IS REMOVED. DBREF 3ZZZ A 156 285 UNP P26599 PTBP1_HUMAN 156 285 DBREF 3ZZZ B 156 285 UNP P26599 PTBP1_HUMAN 156 285 DBREF 3ZZZ C 680 692 UNP Q9CW46 RAVR1_MOUSE 680 692 DBREF 3ZZZ D 680 692 UNP Q9CW46 RAVR1_MOUSE 680 692 SEQADV 3ZZZ GLY C 677 UNP Q9CW46 EXPRESSION TAG SEQADV 3ZZZ ALA C 678 UNP Q9CW46 EXPRESSION TAG SEQADV 3ZZZ MET C 679 UNP Q9CW46 EXPRESSION TAG SEQADV 3ZZZ GLY D 677 UNP Q9CW46 EXPRESSION TAG SEQADV 3ZZZ ALA D 678 UNP Q9CW46 EXPRESSION TAG SEQADV 3ZZZ MET D 679 UNP Q9CW46 EXPRESSION TAG SEQRES 1 A 130 SER VAL GLN SER GLY ASN LEU ALA LEU ALA ALA SER ALA SEQRES 2 A 130 ALA ALA VAL ASP ALA GLY MET ALA MET ALA GLY GLN SER SEQRES 3 A 130 PRO VAL LEU ARG ILE ILE VAL GLU ASN LEU PHE TYR PRO SEQRES 4 A 130 VAL THR LEU ASP VAL LEU HIS GLN ILE PHE SER LYS PHE SEQRES 5 A 130 GLY THR VAL LEU LYS ILE ILE THR PHE THR LYS ASN ASN SEQRES 6 A 130 GLN PHE GLN ALA LEU LEU GLN TYR ALA ASP PRO VAL SER SEQRES 7 A 130 ALA GLN HIS ALA LYS LEU SER LEU ASP GLY GLN ASN ILE SEQRES 8 A 130 TYR ASN ALA CYS CYS THR LEU ARG ILE ASP PHE SER LYS SEQRES 9 A 130 LEU THR SER LEU ASN VAL LYS TYR ASN ASN ASP LYS SER SEQRES 10 A 130 ARG ASP TYR THR ARG PRO ASP LEU PRO SER GLY ASP SER SEQRES 1 B 130 SER VAL GLN SER GLY ASN LEU ALA LEU ALA ALA SER ALA SEQRES 2 B 130 ALA ALA VAL ASP ALA GLY MET ALA MET ALA GLY GLN SER SEQRES 3 B 130 PRO VAL LEU ARG ILE ILE VAL GLU ASN LEU PHE TYR PRO SEQRES 4 B 130 VAL THR LEU ASP VAL LEU HIS GLN ILE PHE SER LYS PHE SEQRES 5 B 130 GLY THR VAL LEU LYS ILE ILE THR PHE THR LYS ASN ASN SEQRES 6 B 130 GLN PHE GLN ALA LEU LEU GLN TYR ALA ASP PRO VAL SER SEQRES 7 B 130 ALA GLN HIS ALA LYS LEU SER LEU ASP GLY GLN ASN ILE SEQRES 8 B 130 TYR ASN ALA CYS CYS THR LEU ARG ILE ASP PHE SER LYS SEQRES 9 B 130 LEU THR SER LEU ASN VAL LYS TYR ASN ASN ASP LYS SER SEQRES 10 B 130 ARG ASP TYR THR ARG PRO ASP LEU PRO SER GLY ASP SER SEQRES 1 C 16 GLY ALA MET GLY SER SER GLU GLY LEU LEU GLY LEU GLY SEQRES 2 C 16 PRO GLY PRO SEQRES 1 D 16 GLY ALA MET GLY SER SER GLU GLY LEU LEU GLY LEU GLY SEQRES 2 D 16 PRO GLY PRO HET IOD A1285 1 HET IOD A1286 1 HET IOD A1287 1 HET IOD A1288 1 HET IOD D1689 1 HETNAM IOD IODIDE ION FORMUL 5 IOD 5(I 1-) FORMUL 10 HOH *132(H2 O) HELIX 1 1 THR A 196 SER A 205 1 10 HELIX 2 2 LYS A 206 GLY A 208 5 3 HELIX 3 3 ASP A 230 ASP A 242 1 13 HELIX 4 4 THR B 196 SER B 205 1 10 HELIX 5 5 LYS B 206 GLY B 208 5 3 HELIX 6 6 ASP B 230 ASP B 242 1 13 SHEET 1 AA 7 SER A 272 ASP A 274 0 SHEET 2 AA 7 VAL A 210 LYS A 218 -1 O ILE A 213 N ARG A 273 SHEET 3 AA 7 GLN A 221 TYR A 228 -1 O GLN A 221 N LYS A 218 SHEET 4 AA 7 VAL A 183 GLU A 189 -1 O LEU A 184 N LEU A 226 SHEET 5 AA 7 CYS A 250 PHE A 257 -1 O THR A 252 N GLU A 189 SHEET 6 AA 7 ASN A 245 TYR A 247 -1 N ILE A 246 O CYS A 251 SHEET 7 AA 7 GLY C 684 LEU C 686 1 N LEU C 685 O ASN A 245 SHEET 1 BA 6 ASN B 245 TYR B 247 0 SHEET 2 BA 6 CYS B 250 PHE B 257 -1 O CYS B 250 N TYR B 247 SHEET 3 BA 6 VAL B 183 GLU B 189 -1 O ARG B 185 N ASP B 256 SHEET 4 BA 6 PHE B 222 TYR B 228 -1 O PHE B 222 N VAL B 188 SHEET 5 BA 6 VAL B 210 THR B 217 -1 N LEU B 211 O GLN B 227 SHEET 6 BA 6 SER B 272 ASP B 274 -1 O ARG B 273 N ILE B 213 SSBOND 1 CYS A 250 CYS A 251 1555 1555 2.05 SSBOND 2 CYS B 250 CYS B 251 1555 1555 2.05 SITE 1 AC1 2 LYS A 259 IOD A1286 SITE 1 AC2 3 SER A 258 IOD A1285 IOD A1288 SITE 1 AC3 3 LYS A 266 SER A 272 SER C 682 SITE 1 AC4 1 IOD A1286 SITE 1 AC5 2 SER B 258 LEU D 688 CRYST1 74.480 60.380 61.060 90.00 107.86 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013426 0.000000 0.004326 0.00000 SCALE2 0.000000 0.016562 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017207 0.00000 MTRIX1 1 -0.198300 0.037110 0.979400 -47.41000 1 MTRIX2 1 -0.049780 -0.998400 0.027750 -9.58900 1 MTRIX3 1 0.978900 -0.043250 0.199900 17.22000 1